Eczema Herpeticum (Kaposi Varicelliform Eruption)
What is Eczema Herpeticum (Kaposi Varicelliform Eruption)?
Eczema herpeticum is a widespread and potentially serious skin infection that occurs when the herpes simplex virus spreads across damaged skin. It most commonly affects people who already have atopic dermatitis, also known as eczema. The virus takes advantage of the broken skin barrier to spread rapidly across large areas of the body.
This condition is also called Kaposi varicelliform eruption. It requires urgent medical attention because the infection can spread quickly and lead to serious complications. The herpes simplex virus type 1, which commonly causes cold sores, is usually responsible. Without prompt treatment, the infection can affect the eyes, internal organs, and become life threatening.
People with eczema face higher risk because their skin barrier is already compromised. The condition creates an opening for the virus to enter and multiply. Early recognition and treatment can prevent severe complications and speed recovery.
Symptoms
- Groups of painful blisters that spread quickly across eczema patches
- Fluid filled bumps that look similar to chickenpox
- Blisters that break open and weep clear or yellowish fluid
- Crusted sores with a punched out appearance
- High fever, often above 102 degrees Fahrenheit
- Swollen lymph nodes in the neck, armpits, or groin
- Severe pain or burning sensation on affected skin
- Feeling extremely tired or unwell
- Loss of appetite
- Chills and body aches
Symptoms typically develop suddenly over 7 to 10 days. The blisters usually appear in areas where eczema has already damaged the skin barrier. If you have eczema and develop rapidly spreading blisters with fever, seek medical care immediately.
Concerned about Eczema Herpeticum (Kaposi Varicelliform Eruption)? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Eczema herpeticum happens when herpes simplex virus type 1 or type 2 infects damaged skin. People with atopic dermatitis have a weakened skin barrier that allows the virus to enter and spread. The infection often occurs during an eczema flare when the skin is most vulnerable. You can get the virus through direct contact with someone who has active cold sores or genital herpes, even if their symptoms seem mild.
Several factors increase your risk of developing this condition. Having moderate to severe eczema creates more opportunities for viral entry. A weakened immune system makes it harder to fight off the infection. Young children face higher risk because their immune systems are still developing. Using topical steroids for eczema management may suppress local immune responses. Previous exposure to HSV-1, shown by positive antibody testing, indicates you carry the virus that could reactivate during eczema flares.
How it's diagnosed
Doctors diagnose eczema herpeticum by examining your skin and asking about your medical history. The appearance of grouped blisters spreading across eczema affected areas is often distinctive. Your doctor may take a swab from the blisters to test for herpes simplex virus. This viral culture or PCR test confirms the diagnosis within a few days.
Blood testing helps identify if you have been exposed to herpes simplex virus in the past. Rite Aid offers HSV-1 IgG testing as an add on to understand your baseline virus status. This antibody test shows whether you carry HSV-1, which puts you at risk for eczema herpeticum if you have atopic dermatitis. Knowing your HSV status helps you and your doctor create a prevention plan and stay alert for early warning signs.
Treatment options
- Antiviral medications like acyclovir or valacyclovir to stop virus replication
- Intravenous antivirals if the infection is severe or spreading rapidly
- Pain relief medications to manage discomfort
- Careful wound care to prevent bacterial infection of open sores
- Stopping topical steroid use temporarily under doctor guidance
- Staying hydrated and getting plenty of rest
- Avoiding contact with others to prevent viral spread
- Keeping skin moisturized once healing begins
- Long term antiviral suppression therapy if you have frequent outbreaks
- Working with a dermatologist to better manage underlying eczema
Need testing for Eczema Herpeticum (Kaposi Varicelliform Eruption)? Add it to your panel.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Eczema is a chronic skin condition that causes dry, itchy, inflamed patches. Eczema herpeticum is a viral infection that occurs on top of existing eczema when herpes simplex virus spreads across the damaged skin. While eczema is manageable at home, eczema herpeticum is a medical emergency requiring antiviral treatment.
Eczema herpeticum can spread very rapidly, often within 7 to 10 days. The viral blisters may appear suddenly and expand across large areas of skin where eczema has compromised the protective barrier. This rapid spread is why immediate medical attention is critical. Early antiviral treatment stops the virus from multiplying and prevents serious complications.
Yes, you can get eczema herpeticum even without a history of cold sores. You may contract the virus through contact with someone else who has active herpes lesions. Some people carry HSV-1 without ever having symptoms themselves. If you have eczema, this silent infection can still cause eczema herpeticum during a flare when your skin barrier is weakened.
Yes, eczema herpeticum is highly contagious while blisters are present and weeping fluid. The fluid contains active herpes virus that can spread to others through direct contact. You should avoid close contact with others, especially babies, pregnant women, and people with weakened immune systems. Careful hand washing and covering lesions help prevent transmission until the sores have completely crusted over.
Doctors typically use a viral culture or PCR test from a blister swab to confirm eczema herpeticum. These tests identify herpes simplex virus DNA in the fluid. Blood tests like HSV-1 IgG show past exposure to the virus and help assess risk in people with eczema. Rite Aid offers HSV-1 IgG testing to check your baseline herpes status if you have atopic dermatitis.
Yes, eczema herpeticum can recur if you have chronic eczema and carry the herpes virus. Each eczema flare creates an opportunity for the virus to reactivate and spread. Your doctor may recommend suppressive antiviral therapy if you experience repeated episodes. Better eczema management through moisturizers, gentle skincare, and anti inflammatory treatments reduces recurrence risk.
Testing for HSV-1 antibodies can be helpful if you have moderate to severe eczema. Knowing your herpes status helps you understand your risk for eczema herpeticum. A positive HSV-1 IgG test means you should watch carefully for early signs during eczema flares. Your doctor can create a prevention plan and provide antiviral medication quickly if needed.
Eczema herpeticum is caused by herpes simplex virus and creates grouped blisters with a punched out appearance. Impetigo is a bacterial skin infection that causes honey colored crusted sores. Both can occur in people with eczema, but they require different treatments. Eczema herpeticum needs antiviral medications, while impetigo responds to antibiotics.
Without prompt treatment, eczema herpeticum can lead to serious complications. The virus may spread to the eyes and cause vision threatening keratitis. Widespread infection can lead to sepsis or organ involvement. Bacterial superinfection of the open sores is common and requires antibiotics. These risks make early recognition and antiviral treatment essential for anyone with eczema who develops suspicious blisters.
Prevention focuses on maintaining a healthy skin barrier and avoiding herpes virus exposure. Keep your eczema well controlled with regular moisturizing and prescribed treatments. Avoid close contact with people who have active cold sores or genital herpes. Wash your hands frequently and avoid touching your face. If you know you carry HSV-1, work with your doctor on an action plan for early antiviral treatment during eczema flares.